跳至主要内容
临床试验/NCT05240872
NCT05240872已完成3 期

Is There Any Advantage of PRP Over Autologous Blood Injection in the Treatment of Chronic Plantar Fasciitis? A Prospective Randomized Double Blinded Study

Istanbul Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年3月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Changes in American Orthopaedic Foot & Ankle Society (AOFAS ) Score

研究概览

简要总结

To explore effects of Autologous Blood Injection versus Platelet Rich plasma injection for treatment of chronic plantar fasciitis

详细描述

After clinical diagnosis of patients with plantar fasciitis. Patients were divided into two groups. Group A (PRP injection group) and Group B (ABI group) were randomized according to web based block group randomization. Patients were evaluated prior to injection in terms of Health related quality of life scores related to foot and ankle diseases (AOFAS and FADI) and VAS. After injection at 1st, 3rd and 6th months HRQoL were compared between groups. Intra group evaluation for HRQoL were performed at f/up visits. Independent t test and repeated measure ANOVA test used for statistical analysis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants who were diagnosed with chronic plantar fasciitis
  • •Nonresponded to o conservative treatment (stretching exercises, nonsteroidal anti-inflammatory drugs, and heel pads) for at least 6 weeks
  • •Patient should be able to understand the informed consent about type of treatment and blindness and randomization
  • •Visual analog scale pain higher than 5 (on a 10-point visual analog scale)

排除标准

  • •previous history of any type of local injection treatment for heel pain
  • •history of surgery for heel pain, foot and ankle disorders, fractures
  • •Associated pathology involving the lower limb such as
  • •tarsal tunnel syndrome
  • •effusion of the ankle indicating an intra-articular disease
  • •Peroneal/Achilles/tibialis tendons pathology
  • •any obvious deformity of foot and ankle,
  • •Patients with systemic disorder like diabetes mellitus, ankylosing spondylitis rheumatoid arthritis, hematological disease, or gout
  • •Use of antiocoagulation -

研究组 & 干预措施

Group A

Active Comparator

Platelet Rich Plasm (PRP) injection group

干预措施: PRP injection (Biological)

Group B

Active Comparator

Autologous Blood injection (ABI) group

干预措施: ABI injection (Biological)

结局指标

主要结局

Changes in American Orthopaedic Foot & Ankle Society (AOFAS ) Score

时间窗: 0,1 st 3rd and 6th month; changes between time points will be assessed

American Orthopaedic Foot \& Ankle Society (AOFAS) Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes Evaluation:0 worst 100 best

Changes in Visual Analogue Scale (VAS)

时间窗: 0,1 st 3rd and 6th month; changes between time points will be assessed

Visual Analogue Scale 10 worst 0-1 best in terms of pain outcome

Changes in Foot and Ankle Disability Index (FADI)

时间窗: 0,1 st 3rd and 6th month; changes between time points will be assessed

Foot and Ankle Disability Index Evaluation:0 worst 100 best

次要结局

未报告次要终点

研究者

发起方
Istanbul Training and Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Ozcan Kaya

Orthopaedics and Traumatology Specialist

Istanbul Training and Research Hospital

研究点 (1)

Loading locations...

相似试验